clinical trial · NCT06545916
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
Alcohol Use DisorderSunobinopPlacebo to match sunobinop
brief summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
started
Oct 14, 2024
primary completion
May 5, 2026
completion
May 5, 2026
last updated
Jun 5, 2026
official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol